Objectives: 1. Describe how torsades develops 2. Differentiate between prolonged QTc and risk of torsades 3. Describe the weaknesses of current data on cardiac risk from azithromycin and levofloxacin

Objectives: 1. Recall the 4 types of immune mediated allergic reactions 2. Differentiate between IgE and IgG mediated reactions 3. Describe the consequences of a falsely reported penicillin allergy View Next

Objectives: 1. Recall the 2 things nurses most want pharmacists to do at codes and rapid responses 2. Describe how to select a patient weight for weight-based meds in an emergency 3. Discuss how to approach nursing leadership to start a pharmacist presence at codes at your hospital if one does not already exist View […]

Objectives: 1. Describe the concerns and priorities managing a myasthenia crisis 2. Describe the issues with paralytic use in patients with myasthenia crisis 3. Recall when to hold and restart Mestinon in a patient with a myasthenia crisis View Previous View Next

Objectives: 1. Describe the evidence for IV lidocaine for analgesia in the ED 2. Describe the indications for IV lidocaine for analgesia in the ED 3. Recall safety concerns for IV lidocaine for analgesia in the ED View Previous View Next

Objectives: 1. Describe the clinical concern drug fever presents 2. Describe the types of fever patterns 3. Recall the most likely causes of drug fever View Previous View Next

Objectives: 1. Describe how to monitor anti-rejection medications for ICU patients 2. Describe how to monitor anti-epileptic medications for ICU patients 3. Recall exceptions to mycophenolate monitoring View Previous View Next

Objectives: 1. Describe case reports of harm with linezolid and serotonergic medications 2. Describe management strategies when using linezolid and serotonergic medications together 3. Recall the signs and symptoms of serotonin syndrome

Objectives: 1. Describe the available reversal agents for DOACs 2. Identify the difference between a reversal agent and a “pro-hemostatic attempt” View Previous View Next

Objectives: 1. Describe safety benefits and risks of using a PCA 2. Describe dosing titration strategies for PCA View Previous View Next

Objectives: 1. Describe the difference between cystitis and pyelonephritis 2. List antibiotic duration for common UTI dosing regimens

Objectives: 1. Describe a suggested protocol for antiplatelet bridging. 2. Identify the level of evidence behind the decision to bridge antiplatelets in the perioperative setting. View Previous View Next